Skip to main content
. 2021 Sep 3;12:671201. doi: 10.3389/fimmu.2021.671201

Figure 5.

Figure 5

Experimental validation of infiltrating immune cells in clinical endometrial samples. (A) Representative photographs of haematoxylin-eosin (HE) staining and immunohistochemistry (CD45, CD8, CD56, CD117, and CD163). Magnifications at 100× and 400× are shown. (B) Boxplots comparing the proportions of four immune cell subsets between normal and endometriosis tissues. Data were assessed by the Wilcoxon rank-sum test, and P values are labelled. ns, no significance. (C, D) The ROC curve of CD8+ T cells and CD163+ macrophages in clinical samples. AUC, the area under the ROC curve. (E) Representative photographs of immunofluorescence (CD8, CD163, and DAPI). Magnification was 400×. *P < 0.05, ***P < 0.001, ns, no significance.